Cargando…

Original Antigenic Sin and Respiratory Syncytial Virus Vaccines

The original antigenic sin (OAS) theory considers the outcome of the first encounter with an antigen. It favors a memory response to the original antigen upon exposure to a similar or related antigen, and includes both positive and negative impacts of past exposure on the memory response to challeng...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripp, Ralph A., Power, Ultan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789633/ https://www.ncbi.nlm.nih.gov/pubmed/31500131 http://dx.doi.org/10.3390/vaccines7030107

Ejemplares similares

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
por: Broadbent, Lindsay, et al.
Publicado: (2015)

The Wages of Original Antigenic Sin
por: Morens, David M., et al.
Publicado: (2010)

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
por: Jorquera, Patricia A., et al.
Publicado: (2016)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)

SARS-CoV-2 vaccination in the context of original antigenic sin
por: Petráš, Marek, et al.
Publicado: (2021)

Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods
por: Smith, Trevor R. F., et al.
Publicado: (2017)

Absence of “Original Antigenic Sin” in Autoimmunity Provides an Unforeseen Platform for Immune Therapy
por: Steinman, Lawrence
Publicado: (1999)

Patient equity and respiratory syncytial virus Immunoprophylaxis
por: Cody Meissner, H.
Publicado: (2019)

Potential resurgence of respiratory syncytial virus in Canada
por: Lavoie, Pascal M., et al.
Publicado: (2021)

Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis
por: Tripp, Ralph A.
Publicado: (2013)

Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection
por: Glaser, Lena, et al.
Publicado: (2019)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
por: Atherton, Lydia J., et al.
Publicado: (2019)

Bioconjugated nanoparticle detection of respiratory syncytial virus infection
por: Tripp, Ralph A, et al.
Publicado: (2007)

Respiratory Syncytial Virus During Pregnancy
por: Polack, Fernando P
Publicado: (2018)

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle
por: Atkins, Katherine E, et al.
Publicado: (2023)

A novel host factor for human respiratory syncytial virus
por: Mehedi, Masfique, et al.
Publicado: (2017)

Respiratory syncytial virus with ongoing COVID-19: is it an emerging threat?
por: Sah, Ranjit, et al.
Publicado: (2023)

The original sins of clinical trials with intravenous immunoglobulins in sepsis
por: Almansa, Raquel, et al.
Publicado: (2015)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Murray, Jackelyn, et al.
Publicado: (2022)

The Burden of Respiratory Syncytial Virus Infection in Adults and Reproductive-Aged Women
por: Gonik, Bernard
Publicado: (2019)

Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017
por: Kim, Doyoung, et al.
Publicado: (2019)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
por: Hong, Suyeon, et al.
Publicado: (2021)

Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection
por: Thorburn, Kentigern, et al.
Publicado: (2006)

Infant respiratory syncytial virus infection and childhood asthma: A shift in the paradigm?
por: Rosas‐Salazar, Christian, et al.
Publicado: (2023)

Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity
por: Park, Mee Sook, et al.
Publicado: (2016)

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection
por: Pålsson, Sandra Axberg, et al.
Publicado: (2020)

The Respiratory Syncytial Virus G Protein Conserved Domain Induces a Persistent and Protective Antibody Response in Rodents
por: Nguyen, Thien N., et al.
Publicado: (2012)

Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication
por: Mathew, Cynthia, et al.
Publicado: (2021)

Small Non-coding RNA Expression Following Respiratory Syncytial Virus or Measles Virus Infection of Neuronal Cells
por: Bakre, Abhijeet A., et al.
Publicado: (2021)

Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells
por: Villenave, Rémi, et al.
Publicado: (2011)

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein
por: Flynn, Jessica A., et al.
Publicado: (2016)

Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication
por: Bakre, Abhijeet, et al.
Publicado: (2012)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2023)

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
por: Detalle, Laurent, et al.
Publicado: (2015)

Continuous Invasion by Respiratory Viruses Observed in Rural Households During a Respiratory Syncytial Virus Seasonal Outbreak in Coastal Kenya
por: Munywoki, Patrick K, et al.
Publicado: (2018)

"Original Antigenic Sin" in SARS-CoV-2 Vaccination Followed by Infection
por: Castillo-Aleman, Yandy M, et al.
Publicado: (2022)

Attenuated Respiratory Syncytial Virus Vaccines in Asthmatic Children
por: Mcintosh, Kenneth, et al.
Publicado: (1974)

SARS-CoV-2 vaccination washes away original antigenic sin
por: Pillai, Shiv
Publicado: (2022)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k76hg05hsura0o61fvjgeij2lq